FMR CORP 13D and 13G filings for Rapport Therapeutics, Inc. Common Stock:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-12 10:34 am Purchase |
2024-11-08 | 13G | Rapport Therapeutics, Inc. Common Stock RAPP |
FMR CORP | 5,486,468 14.999% |
503,117 (+10.10%) |
Filing |
| 2024-07-10 10:10 am Purchase |
2024-07-09 | 13G | Rapport Therapeutics, Inc. Common Stock RAPP |
FMR CORP | 4,983,351 13.624% |
4,983,351 (New Position) |
Filing |